IP Library Granted Patent US 9,140,684
Granted Patent B2
US 9,140,684 · App. 13/663,339 · Granted Sep 22, 2015

Device to expose cells to fluid shear forces and associated systems and methods

Inventors: Nathan J. Sniadecki (Seattle, WA); Lucas Ting (Seattle, WA)
Assignee: University of Washington through its Center for Commercialization
G01N33/4905C12M35/04C12M41/46G01N33/5302B01L3/502746
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,140,684
App. No.
13/663,339
Granted
Sep 22, 2015
Kind
B2
Abstract

The present technology relates generally to devices to expose cells to fluid shear forces and associated systems and methods. In particular, several embodiments are directed toward devices to expose cells to fluid shear forces in order to measure changes in internal cell forces. In some embodiments, a fluidic device includes a flow unit configured to induce fluid flow through the device. The device further includes a fluid channel configured to accept a biological sample dispersed on an array of flexible structures. The flow unit can be configured to induce disturbed and/or laminar flow in the fluid channel. The device can further include optical or magnetic detection means configured to measure a degree of deflection of one or more flexible structures in the array.

Claims (11)

1. An analytic method, comprising:

placing a plurality of flexible microposts in a fluid flow chamber, wherein a plurality of cells is dispersed over at least two of the plurality of microposts;

flowing fluid over the microposts, wherein flowing fluid includes inducing laminar and disturbed flow to the plurality of cells; and

measuring a deflection of the microposts.

2. The method of claim 1 wherein inducing laminar and disturbed flow comprises flowing fluid over a backward-facing step in the fluid flow chamber, wherein the laminar and disturbed flow occur downstream of the step.

3. The method of claim 1 wherein placing the plurality of microposts includes placing microposts having human pulmonary artery endothelial cells bound thereto.

4. The method of claim 1 , further comprising placing an air chamber in the fluid flow chamber to induce a steady flow rate.

5. The method of claim 1 wherein flowing fluid over the microposts comprises flowing a fluid containing at least one of a drug, reagent, nucleotide, protein.

6. The method of claim 1 , further comprising determining an intercellular tension between at least two of the plurality of cells based on the measured deflection.

7. The method of claim 1 , wherein at least one of the plurality of cells is in simultaneous, direct contact with two of the microposts.

8. The method of claim 1 , further comprising seeding the plurality of cells over and across the top surfaces of the microposts.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 12, 2014
From: UNIVERSITY OF WASHINGTON / CENTER FOR COMMERCIALIZATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032436/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2013
From: SNIADECKI, NATHAN J.; TING, LUCAS
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 030100/0582 →
Continuity (4)
Provisional Application 61709809 · Oct 4, 2012
Provisional Application 61645191 · May 10, 2012
Provisional Application 61552052 · Oct 27, 2011
Related Publication 20130109012A1 · May 2, 2013